About Regenica
Regenica is a Healthcare company based in San Diego (United States) founded in 2008, and was acquired by Allergan in July 2017. Anti-aging skin care products are developed using growth factor technology. The company was acqui-hired. Its focus areas include Life Sciences, Dermatology, Drugs and Aesthetics. Its competitors include Revance Therapeutics, Castle Creek Pharma and Dermavant; 3 of its 3 listed competitors have raised funding.
Company details
Regenica was founded in 2008 and is based in San Diego, United States. Operations focus on the cosmetics sector, where anti-aging skin care items are manufactured through regenerative science. Key products encompass a rejuvenating dual serum, replenishing creme, renew SPF 25, repair complex, revitalizing eye creme, and recovery gel. These items utilize skin rejuvenation growth factor technology for formulation.
- Headquarters San Diego, United States
- Stage Acquired
- SectorsHealthcare
- Website regenica.com
- Social X Facebook Instagram
- Acquired by Allergan (Jul 2017)
Investors in Regenica
Regenica has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Allergan.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
A portfolio of generic medicines is developed and manufactured. | 1948 | allergan.com | Madison, United States |
Investor details for Regenica
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Regenica
2 dated milestones of Regenica across 9 years, from founding to its latest funding, stage changes and deals.
- Founded Regenica is founded.
- Exit Acquired by Allergan.
Competitors of Regenica
Regenica has 3 listed competitors in our database, 3 of them funded. They include Revance Therapeutics, Castle Creek Pharma and Dermavant.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| revance.com | 2002 | Newark, United States | $154.56M | 597 | Neurotoxin products for aesthetic and therapeutic skin treatments are developed. | |
| castlecreekpharma.com | 2015 | Basking Ridge, United States | $663.15M | 72 | Drugs for skin diseases, ENT disorders, and rare diseases such as urea cycle disorders | |
| dermavant.com | 2016 | Phoenix, United States | $160M | Small molecule therapeutics for inflammatory skin diseases are developed. |
Detailed competitors of Regenica
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Dermatology
3 companies that operate in the same segment as Regenica (Dermatology) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Neurotoxin products for aesthetic and therapeutic skin treatments are developed. | 2002 | Newark, New Jersey, United States | USD 154.56 M | USD 234.04 M | 597 | |
Diagnostic tests for cancer prognosis are provided. | 2008 | Friendswood, Texas, United States | USD 61.97 M | USD 344.23 M | 761 | |
Adhesive patch biopsies for skin cancer detection are provided. | 1996 | San Diego, California, United States | USD 24.37 M | USD 15.3 M | 259 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Regenica
Regenica was founded in 2008.
Regenica is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Regenica was founded in 2008 and is based in San Diego, United States. Operations focus on the cosmetics sector, where anti-aging skin care items are manufactured through regenerative science. Key products encompass a rejuvenating dual serum, replenishing creme, renew SPF 25, repair complex, revitalizing eye creme, and recovery gel. These items utilize skin rejuvenation growth factor technology for formulation.
Regenica's top competitors include Revance Therapeutics, Dermavant and Castle Creek Pharma.
Regenica has 1 investor. Key investors include Allergan.
Yes. Regenica was acquired by Allergan in July 2017.
